Kim M. Kerr - Concepedia

Author

Kim M. Kerr

University of California San Diego ORCID

Also Known As

K Kerr, K M Kerr, K. Kerr, K.M. Kerr, KIM M. KERR, KIM M. KERR, Kim Kerr, Kim M Kerr, Kim M. KERR, Kim M. Kerr

129

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego University of California System University of California San Diego Medical Center Pulmonary and Critical Care Associates Aberdeen Royal Infirmary

About

Kim M. Kerr is an author at University of California San Diego specializing in medicine, thrombosis, and pulmonary vascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	3.2K
2	Public Health	9	9	705
3	Engineering	2	2	725
4	Nursing	1	1	77
5	Social Sciences	1	1	77

Kim M. Kerr

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection Robert T. Schooley, Biswajit Biswas, Jason J. Gill, Antimicrobial Agents and Chemotherapy	2017	1.2K
Pulmonary endarterectomy: experience and lessons learned in 1,500 cases Stuart W. Jamieson, David P. Kapelanski, Naohide Sakakibara, The Annals of Thoracic Surgery Interventional PulmonologyPulmonary EndarterectomyThoracic SurgeryPulmonary MedicineSurgery	2003	762
Genome-Wide RNAi Analysis of Growth and Viability in <i>Drosophila</i> Cells Michael Boutros, Amy A. Kiger, Susan Armknecht, Science EngineeringGeneticsMolecular GeneticsFunctional AnalysisEssential Genes	2004	704
Pulmonary Endarterectomy: Recent Changes in a Single Institution's Experience of More Than 2,700 Patients Michael M. Madani, William R. Auger, Victor Pretorius, The Annals of Thoracic Surgery Interventional PulmonologyPulmonary EndarterectomyThoracic SurgeryMore Than 2,700Pulmonary Medicine	2012	592
Ozone-induced Airway Inflammation in Human Subjects as Determined by Airway Lavage and Biopsy Robert M. Aris, Dorothy Christian, Patrick Q. Hearne, American Review of Respiratory Disease	1993	325
Long-Term Outcome after Pulmonary Thromboendarterectomy Carol J. Archibald, William R. Auger, Peter F. Fedullo, American Journal of Respiratory and Critical Care Medicine HypertensionSurgeryThrombosisVenous ThrombosisHematology	1999	315
RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini, The Lancet Respiratory Medicine	2017	262
Pulmonary Hypertensive Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension Before Pulmonary Thromboendarterectomy Kurt Jensen, Kim M. Kerr, Peter F. Fedullo, Circulation	2009	196
Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension Paul Bresser, Peter F. Fedullo, William R. Auger, European Respiratory Journal	2004	149
“High Probability” Perfusion Lung Scans in Pulmonary Venoocclusive Disease Colleen Bailey, Richard N. Channick, William R. Auger, American Journal of Respiratory and Critical Care Medicine	2000	112

Page 1